chr6-160702270-G-A

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000301.5(PLG):​c.-35G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00755 in 1,608,996 control chromosomes in the GnomAD database, including 355 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.028 ( 165 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 190 hom. )

Consequence

PLG
NM_000301.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 2.92
Variant links:
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 6-160702270-G-A is Benign according to our data. Variant chr6-160702270-G-A is described in ClinVar as [Benign]. Clinvar id is 1248531.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0829 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLGNM_000301.5 linkuse as main transcriptc.-35G>A 5_prime_UTR_variant 1/19 ENST00000308192.14
PLGNM_001168338.1 linkuse as main transcriptc.-35G>A 5_prime_UTR_variant 1/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLGENST00000308192.14 linkuse as main transcriptc.-35G>A 5_prime_UTR_variant 1/191 NM_000301.5 P1

Frequencies

GnomAD3 genomes
AF:
0.0279
AC:
4247
AN:
152170
Hom.:
166
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0854
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0187
Gnomad ASJ
AF:
0.0271
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.00342
Gnomad OTH
AF:
0.0287
GnomAD3 exomes
AF:
0.0109
AC:
2529
AN:
231250
Hom.:
80
AF XY:
0.00898
AC XY:
1126
AN XY:
125406
show subpopulations
Gnomad AFR exome
AF:
0.0910
Gnomad AMR exome
AF:
0.0127
Gnomad ASJ exome
AF:
0.0274
Gnomad EAS exome
AF:
0.000408
Gnomad SAS exome
AF:
0.00159
Gnomad FIN exome
AF:
0.0000547
Gnomad NFE exome
AF:
0.00360
Gnomad OTH exome
AF:
0.0107
GnomAD4 exome
AF:
0.00542
AC:
7902
AN:
1456708
Hom.:
190
Cov.:
31
AF XY:
0.00519
AC XY:
3763
AN XY:
724686
show subpopulations
Gnomad4 AFR exome
AF:
0.0876
Gnomad4 AMR exome
AF:
0.0141
Gnomad4 ASJ exome
AF:
0.0293
Gnomad4 EAS exome
AF:
0.00212
Gnomad4 SAS exome
AF:
0.00205
Gnomad4 FIN exome
AF:
0.0000388
Gnomad4 NFE exome
AF:
0.00221
Gnomad4 OTH exome
AF:
0.0127
GnomAD4 genome
AF:
0.0279
AC:
4251
AN:
152288
Hom.:
165
Cov.:
32
AF XY:
0.0263
AC XY:
1955
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.0853
Gnomad4 AMR
AF:
0.0186
Gnomad4 ASJ
AF:
0.0271
Gnomad4 EAS
AF:
0.000771
Gnomad4 SAS
AF:
0.00228
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00341
Gnomad4 OTH
AF:
0.0284
Alfa
AF:
0.00774
Hom.:
3
Bravo
AF:
0.0326
Asia WGS
AF:
0.00636
AC:
22
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 21, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
15
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4252060; hg19: chr6-161123302; API